Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors. [electronic resource]
Producer: 20170526Description: 959-967 p. digitalISSN:- 1432-0843
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Arsenic -- blood
- Arsenites -- administration & dosage
- Cisplatin -- administration & dosage
- Endpoint Determination
- Enzyme Inhibitors -- administration & dosage
- Female
- Humans
- Long QT Syndrome -- chemically induced
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Platinum -- blood
- Sodium Compounds -- administration & dosage
- Telomerase -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.